KCPG
CMD

Kavar Capital Partners Group’s Cantel Medical Corporation CMD Stock Holding History

Kavar Capital Partners Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-250
Closed -$20K – 492
2019
Q2 		$20K Buy
+250
New +$17.6K 0.01% 315
2018
Q3 		– Sell
-250
Closed -$25K – 425
2018
Q2 		$25K Hold
250
– – 0.01% 241
2018
Q1 		$28K Buy
+250
New +$28K 0.01% 235

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Kavar Capital Partners Group's CMD Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 250 shares — an estimated $20K sold.

Kavar Capital Partners Group first reported a position in CMD in Q1 2018 and held it in 3 quarters. The position peaked at $28K in Q1 2018. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Kavar Capital Partners Group reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
  • Kavar Capital Partners Group sold 250 Cantel Medical Corporation shares in Q3 2019, an estimated $20K.
  • Kavar Capital Partners Group first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 3 quarters.
  • Kavar Capital Partners Group's Cantel Medical Corporation position peaked at $28K in Q1 2018.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.